A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas

By Cameron C. Lee, E. Gillies, M. E. Fox, S. Guillaudeu, J. Fréchet, Edward E Dy, Francis C. Szoka Jr.. Proceedings of the National Academy of Sciences of the United States of America, 2006

604 citations recorded by the source corpus.

Subfields: Biomaterials, Molecular Biology, Polymers and Plastics

View Paper: https://www.semanticscholar.org/paper/c72b2376057491c1cf5d8b163edaf98e46472abc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. O. Mustapha
2. S. Shafique
3. Rajesh K. Singh
4. Izhar Ullah
5. O. S. Qureshi
6. F. Din
7. J. Lillard
8. Alam Zeb

In Molecular Biology

1. O. Mustapha
2. S. Shafique
3. Izhar Ullah
4. O. S. Qureshi
5. F. Din
6. Alam Zeb
7. W. Aman

Citations in the corpus

• Nanoparticle-based targeted drug delivery (2009, methodology): “DOX was conjugated to a biodegradable dendrimer with optimized blood circulation time through the careful design of size and molecular architecture (Lee et al., 2006).”
• Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors (2017, methodology): “unresponsive C-26 tumor when administered subcutaneously into mice.(28) Similarly, in another study, it was observed”